Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$PVSP Pervasip common shareholders will receive 15% or 15,000,000 shares in Artizen Corp at the Record Date
The Record Date is the day end of day before the date at which the new Artizen Ticker goes life
Pervasip are not shortchanged. On an as if fully diluted basis, all Pervasip common shares amount to approximately 13.8% of all outstanding shares; we set 15% aside for all common shareholders in Artizen Corp
$PVSP Holders of Pervasip’s issued and outstanding common shares as of the record date will receive an aggregate of 15,000,000 shares of Artizen common stock, corresponding to 15% of Artizen’s fully diluted issued and outstanding common shares upon completion of the transaction (in addition to retaining their shares in Pervasip). Likewise, holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives. Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities.
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
$PVSP trader's cheat sheet https://www.barchart.com/stocks/quotes/PVSP/cheat-sheet
$PVSP Investment Bankers want PVSP to diversify from just Recreational Cannabis
"Expect a Series of Related Transactions"
$PVSP Pervasip currently has about 5,000,000,000 shares of common stock issued and outstanding, corresponding to about 15% of Pervasip’s fully diluted issued and outstanding common stock. Pervasip additionally has 850,000 shares of Series K convertible preferred stock issued and outstanding, corresponding to 85% of Pervasip’s fully diluted issued and outstanding common stock, as well as various other convertible securities.
https://www.morningstar.com/news/globe-newswire/8730826/pervasip-announces-artizen-spin-off
$PVSP Holders of Pervasip’s issued and outstanding common shares as of the record date will receive an aggregate of 15,000,000 shares of Artizen common stock, corresponding to 15% of Artizen’s fully diluted issued and outstanding common shares upon completion of the transaction (in addition to retaining their shares in Pervasip). Likewise, holders of Pervasip’s Series K and other convertible securities will receive an aggregate of 85,000,000 shares of Artizen common stock, the vast majority of which will be subject to lock-up restrictions prohibiting sales prior to Artizen’s realization of material growth and other performance objectives. Artizen will have 100,000,000 common shares outstanding on a fully diluted basis upon completion of the transaction, with no convertible debt or other securities.
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
$BIEL sells in all these countries!
$PVSP Artizen Corp will have a cleaner, more easily fund able capital structure.
$PVSP PERVASIP will still be managed by the current executive management team.
$PVSP The Company is working with its auditors to complete the required financial audits, including one for Pervasip on a consolidated basis and another for Artizen on a consolidated basis (without Pervasip). Once complete, a Form 10 Registration Statement will be filed with the SEC for Artizen to initiate the spin-off process. Additional information regarding the status and timing of the transaction and the various required regulatory and other approvals will be provided as it becomes available. Pervasip has commenced evaluation of potential targets for acquisition upon completion of the Artizen spin-off.
$IVDN News: Innovative Designs Receives Notice of Allowance on Patent Application
Pittsburgh, PA, Jan. 11, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Innovative Designs (IVDN) is pleased to announce that the United States Patent and Trademark Office (USPTO) has agreed that our patent application defining our proprietary process for forming closed and evacuated cell expanded low density foam is entitled to patent protection. The USPTO has issued a Notice of Allowance and an appropriate patent will issue in due course. A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office (USPTO) after a patent examiner has decided to issue the requested patent. Additional patent applications on other proprietary concepts are also being pursued.
Innovative Designs CEO Joseph Riccelli commented, "This is another step forward in the validation process for our Insultex(R) insulation. Once in place it will open the door for unprecedented growth into apparel many other markets."
Disclaimer:
Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.
Joseph Riccelli
412-799-0350
joer@idigear.com
$IVDN has launched a new company Twitter account to keep investors updated on Insultex, the world's highest performing insulation product. New international marketing contract and other developments covered here:https://twitter.com/riccelli_joseph
Be sure to become a registered Follower of the new IVDN Twitter site.That way you will be automatically notified whenever a new posting is made there.You can also communicate directly with IVDN management on Twitter whenever you have comments or questions.
$AGYP ~ Enerhash CEO, Daniel Jogg, shared news on his LinkedIn of the recently signed MOU to begin the Flare Gas Bitcoin Mining Data Center Project. Check out the caliber of the people taking note of the JV Partnership between Enerhash USA and Allied Energy:
On watch for big updates!
Allied Energy Signs MOU with Enerhash USA to Begin Initial Flare Gas #bitcoin Mining Data Center Project #BitcoinMining $AGYP
https://finance.yahoo.com/news/allied-energy-signs-mou-enerhash-161000005.html
30X Plus - how can it be? Do your own dd and evaluate the risk/reward ratio.
board - https://investorshub.advfn.com/Euro-Sun-Mining-Inc-16633
website - http://www.smartredirect.de/redir/clickGate.php?u=IgKHHLBT&m=1&p=bvjHgP4nHn&t=xZJdYif2&st=&s=&splash=0&abp=1&url=https%3A%2F%2Feurosunmining.com%2F&r=https%3A%2F%2Finvestorshub.advfn.com%2Fboards%2Fread_msg.aspx%3Fmessage_id%3D170676342
$CDSG News: TLC PROJECT EXPANDS LITHIUM RESOURCE AROUND CDSG WELL CLAIMS
News link with geographic illustrations:
https://www.globenewswire.com/news-release/2022/12/14/2573893/0/en/
Las Vegas, NV, Dec. 14, 2022 (GLOBE NEWSWIRE) -- China Dongsheng International Inc., (OTC Markets: CDSG) (the "Company" or "CDSG") is pleased to provide an update on our West End Lithium ("WEL") project located just 6 miles northwest of Tonopah, Nevada.
The WEL project claims are located within, and is surrounded by, the outer boundary of the TLC Project being developed by American Lithium Corp. ("American Lithium") (LI.V) (OTCQB: LIACF). American Lithium has done exceptional work throughout 2022 and has recently released a new NI 43-101 compliant resource for the TLC Project.
Dated November 29, 2022, the combined Measured and Indicated portions of the TLC mineral resource grew from previous calculations of 5.37 Mt to now 8.83 Mt LCE mainly from work conducted in a north and northwest direction from their previous drilling. The image (after American Lithium's news release) shows the boundary of the measured, indicated and inferred resource which now partly engulfs and surrounds the WEL claim boundary.
Figure 1. TLC Resource boundary vs WEL Claim location
In its entirety, the TLC resource is now reported to contain 4.2 Million tonnes (Mt) lithium carbonate equivalent (LCE) measured, 4.63 Mt LCE indicated and 1.86 Mt LCE inferred. The Lithium mineralization is hosted in shallow claystones which the US Geologic survey has identified as underlying both the TLC and WEL claims.
The updated 8.83 Mt LCE measured and indicated resource now stands well above Nevada's multi-billion-dollar Thacker Pass Lithium project of Lithium Americas (NYSE: LAC) which holds 3.13 Mt of Proven and Probable LCE reserves.
The WEL claim area possess excellent access via gravel roads and the proximity to Tonapah offers access to skilled labor, water and electricity. Our Phase One program, which now includes planned drilling, should serve to compliment the growing resource of the TLC area. The Company is looking forward to working with Barrel Energy (OTC: BRLL) on this project.
Figure 2. Location of WEL claims near Tonopah, NV.
About the Company: China Dongsheng International Inc. (OTC Markets: CDSG) is an emerging company based in Nevada. The company's principal activity is acquiring and developing opportunities in the natural resource sector and complimentary technologies.
For further information please visit http://www.cdsgholdings.co. or (702) 595-2247
Forward-Looking Statements:
This press release may contain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements relating to financial results and plans for future development activities and are thus prospective. Forward-looking statements include all statements that are not statements of historical fact regarding intent, belief or current expectations of the Company, its directors or its officers. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company's ability to control. Actual results may differ materially from those projected in the forward-looking statements. Among the factors that could cause actual results to differ materially from those indicated in the forward-looking statements are risks and uncertainties associated with the Company's business and finances in general, including the ability to continue and manage its growth, competition, global economic conditions and other factors discussed in detail in the Company's periodic filings with the Security and Exchange Commission.
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP Artizen™ Developed in the early days of 2014 on the back of years of experience in medical cannabis, the early founding members decided to grow some of the Northwest’s most well-known strains, add new genetics and create a brand of premium flower products that would eventually establish Artizen as one of the premier consumer brands in Washington State
This DFS Gold/Copper Developer Undervalued Is Only The First Name.
When the gold price is moving up - this one has the potential to double -
or triple on a good trading day.
Under the radar mining stock +37.50% 5-Day Change at writing
https://eurosunmining.com/ (TSX and OTC)
https://investorshub.advfn.com/Euro-Sun-Mining-Inc-CPNFF-16633
$IVDN rising on news of European Distribution Agreement with large minimum orders for superior performance insulation ...
Innovative Designs Adds International Distributor
December 7, 2022 (Globe Newswire)
https://www.globenewswire.com/news-release/2022/12/07/2569505/0/en/Innovative-Designs-Adds-International-Distributor.html
Pittsburgh, PA, Dec. 07, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--Innovative Designs (IVDN) has entered into an International Distributorship Agreement with Phoenix Nanotech LTD, Norfolk, England. Phoenix Nanotech LTD will maintain exclusive distribution rights in Commonwealth Countries. The Commonwealth is a voluntary association of 56 independent and equal countries. It is home to 2.5 billion people and includes both advanced economies and developing countries. Thirty-two of the members are small states, including many island nations. The member governments have agreed to shared goals like development, democracy, and peace. The agreement, executed on November 18, 2022, states Phoenix Nanotech LTD will purchase a minimum of 1,000,000 yards of Innovative Design's exclusive insulation Insultex(TM) and a minimum of 1,000 rolls of Insultex House Wrap in a calendar year.
Phoenix Nanotech CEO, Leigh Allison, commented, "We were delighted to sign an international distributorship agreement with Joe at Innovative Designs Inc. The transition towards net-zero by 2050 will involve profound, sometimes disruptive products and 'Insultex' with its global multiple application potential is definitely one of those products."
Innovative Designs Inc CEO, Joseph Riccelli, commented, "We are excited to enter into an agreement with Phoenix Nanotech LTD. We reached an agreement with them to order a substantial quantity of our House Wrap and a minimum of 1,000,000 yards of our Insultex insulation. We are laying the groundwork to meet international demands as well as with continued growth here in the U.S."
Disclaimer:
Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.
Joseph Riccelli
412-799-0350
joer@idigear.com
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$MASN Maison Luxe Continues to Execute Its Growth Plan by Launching Luxury Sneaker E-Commerce Website: Kicks on Demand https://newmediawire.com/news/maison-luxe-continues-to-execute-its-growth-plan-by-launching-luxury-sneaker-e-commerce-website-kicks-on-demand-6848394
$MASN Maison Luxe operates as a niche high-end luxury goods retailer focused within the fine time piece and jewelry segments & lab-grown diamonds producer.
$MASN huge recent news!!! Radar!!! https://finance.yahoo.com/news/mason-graphite-announces-appointment-president-155900920.html
The Rovina valley gold/copper project | euro sun mining Original
1 Feb. 2022 Leading the sector towards a more sustainable and responsible path of providing critical metals to the EU, Euro Sun will produce a clean, high-grade copper concentrate with a strong gold credit at an AISC of US$1.70/ lb.
There is strong demand at European smelters for clean concentrate, with Spain, Germany, Serbia
and Sweden all being strategic markets for the concentrate.
https://investorshub.advfn.com/Euro-Sun-Mining-Inc-CPNFF-16633
(TSX and OTC)
https://eurosunmining.com/
Analysts - https://www.marketscreener.com/quote/stock/EU...consensus/
Feel Free To Share - Sharing Is Caring
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
15,38% + yesterday, 5-Day +26.67%, today?
As we passed the third resistance yesterday - it is now "open" for a jump to about double up
https://eurosunmining.com/
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
SILVER. . . are we there now? Yes, I believe we are. Silver has a clear momentum trend;
Silver Price Performance USD
silver_performance_chart
https://silverprice.org/silver-price-chart.html (the last 30 days 16,5% Up)
TSX - Kootenay Silver; https://ih.advfn.com/stock-market/TSXV/KTN/stock-price
OTC - https://ih.advfn.com/stock-market/USOTC/koote...tock-price
As we move within a clear momentum trend, IMO it is an option to re-fill/take a position.
Do always your own d d - good luck to all.
$IVDN Welcomes Lockheed Martin & NASA Project Veteran to its Board of Directors
News Link:
https://www.globenewswire.com/news-release/2022/12/01/2566189/0/en/Innovative-Designs-Adds-Board-Member.html
Pittsburgh, PA, Dec. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire--Innovative Designs Inc (OTCQB: IVDN)has added Robert K. Adams to its Board of Directors. Mr. Adams graduated from Texas A&I University with a degree in Electrical Engineering.
Throughout his career, Mr. Adams has worked in various capacities. He began his career at the Lockheed Martin Corporation working on various projects for NASA. Mr. Adams then moved onto the Department of Defense as an electrical engineer at Kelly Air Force Base.
Mr. Adams was later recruited to head a cyber security development team for the Department of Defense. His team developed a system to safeguard the various Air Force networks.
Mr. Adams later established his own company, Planck Consulting, to support clients through the investigation of technical and scientific research, government policies and procedures, patent development and engineering concepts.
Mr. Adams commented "My investor relationship with IVDN began almost 14 years ago, and I am extremely proud to be asked to become part of the amazing IVDN management team."
Innovative Designs CEO, Joseph Riccelli, stated, "Adding Mr. Adams to our Board of Directors strengthens the company's ability to quickly solve any issues that may surface and allows us to move forward at a faster rate".
Disclaimer
Certain statements in this press release constitute "forward-looking" statements as defined by federal law. Such statements are based on assumptions, but there is no assurance that actual outcomes will not be materially different as those implied. Any such statements are made in reliance on the "Safe Harbor" protections provided under the Private Securities Reform Act of 1995 and are subject to various factors, including the risks and matters discussed in the Company's SEC filings available at http://www.sec.gov.
Joseph Riccelli
412-799-0350
joer@idigear.com
$PVSP is another gem with a MC of 6-7mil but making $20+ mil with a positive ebitda.
$PVSP Key Highlights
Instead of focusing on a rollout of licensed Dabs and Vape4Less brands, the Company pursued an outright acquisition of those brands plus others, achieving more beneficial long-term value but not yet realizing respective revenue gains as indicated earlier.
Q3 shows margin improvement over Q2 as higher margin brands and products are coming online, a trend that will continue into Q4 2022.
The Company continues to pursue additional operational, financial, and legal restructuring to further clean and strengthen its balance sheet.
While expensive, the Company will continue to seek capital from available equity or debt sources.
The cannabis market on the Westcoast continues to see a dramatic post-pandemic retraction, creating a challenging environment for all producers, processors, and retailers. With an almost 18% contraction in retail revenues, massive oversupply, sustained downward price pressure and increasing costs, the industry is still months away from a recovery, although the bottom for pricing seems to have been reached.
https://www.morningstar.com/news/globe-newswire/8666987/pervasip-announces-3rd-quarter-financials
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$CURR is moving into a new business model focused on the company's very popular lines of wellness and anti-aging products. The latest financial results illustrate the company's growing success on this new path.
CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins
New Marketing Programs Showing Encouraging Early Results
SHERMAN OAKS, CA / ACCESSWIRE / November 22, 2022 / CURE Pharmaceutical Holding Corp. (OTCQB:CURR) ("CURE" or the "Company"), a proprietary broad platform technology and wellness company, today announced results for the quarter ended September 30, 2022.
Key operational highlights included the following:
Revenue in the third quarter surged 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million with further increases expected in Q4.
Gross margins for the third quarter improved by 123 basis points to 80.0% in 2022 compared to the same period in 2021 with expectations of continuing high margin sales with our new marketing initiatives.
SG&A expenses (excluding non-cash charges) for the third quarter decreased by $0.1 million in 2022 compared to 2021.
Cost reductions and operating leverage helped narrow operating loss (excluding non-cash charges) by $0.6 million in 2022 versus 2021 despite enhanced marketing investment.
"We are very pleased with our results and accelerating sales in the third quarter which reflect the improving trajectory of the business. The proceeds from the recent asset sale will enable us to invest in the future of the Company. Our margin expansion initiatives continue to deliver results, and we are continuing our efforts to reduce SG&A expenses to maximize operating leverage. We are also very excited about the launches of the advertising and marketing campaigns for our Nutri-Strips and Seratopical Revolution lines, both of which have proprietary delivery system technologies. Lastly, the new technologies that Rob Davidson and his team are developing for the Company look very promising," said Nancy Duitch, Cure Pharmaceutical CEO.
Operational Highlights
Other operational highlights during the third quarter of 2022 included:
CURE completed the sale of a portion of its platform technology intellectual property portfolio and related assets in July 2022 for $20 million of non-dilutive capital in total consideration. A portion of the cash proceeds was used to pay down certain debt obligations and the balance will be used for working capital and to grow the Company's intellectual property portfolio and its wellness and beauty brands. The Company retained 15 of its patents and will continue to be an incubator for future technologies and patents, which it intends to monetize through the commercialization of the technologies through product development or through the licensing or sale of the technologies.
The Company is focused on becoming the future of wellness with its long-term growth strategy to increase revenue with high margins by using its incubator strategy, product development and marketing and through strategic partnerships and geographic licensing deals. These initiatives, along with the Company's relationships with Nicole Kidman and other major social media influencers, will also help propel its health and beauty brands to become household names and the Company to become a genuine house of recognizable and respected quality brands.
CURE's wholly owned subsidiary, The Sera Labs, also announced that six SKUs of its Seratopical Revolution skincare line with P3P, the proprietary delivery system, are now being sold at 1,372 Walmart Stores as well as on Amazon.com.
Sera Labs also has garnered placement for its revolutionary oral thin film strip, Nutri-Strips™ on shelves at CVS, Amazon.com and Target.com. Nutri-Strips are proprietary to Sera Labs and are the result of years of research.
We have recently enhanced the reach and visibility of our Brand Ambassador, actress Nicole Kidman, as part of the launch of our new transformational Seratopical Revolution and Nutri-Strips marketing campaigns and the unveiling of our revolutionary new delivery system for our plant-based skincare line. Nicole Kidman and our CEO will have more prominence in these multi-faceted marketing programs including recent articles like the ones in Forbes and Impact Wealth. To view the articles, click on the following links:
Forbes Oct 31, 2022 - Nicole Kidman Talks Skincare-And The Beauty Essentials She Always Has In Her Bag
Impact Wealth Oct 31, 2022 - The Powerful Impact of Beauty Market Revealed by CEO Nancy Duitch
Board of Directors and Governance Update
On August 2, 2022, CURE announced the appointment of Gerald Bagg to its Board of Directors. This strategic addition adds depth to CPG and advertising. A 45+ year veteran of the advertising industry, Gerald is best known for pioneering the BRAND RESPONSE advertising approach to campaigns. He is the Chairman and a co-founder of Quigley-Simpson Inc., a more than twenty-year-old full-service advertising agency specializing in strategic planning, marketing, media planning and buying, brand building, creative development, and production. Quigley-Simpson clients include some of the largest consumer goods companies with some of the most well-known brands in the world including over 60 brands from Proctor & Gamble.
On August 16, 2022, the Company announced the appointment of former CURE CEO Rob Davidson as Chairman of its Board of Directors. In addition, the Company announced the appointment of Robert J. Costantino to its Board of Directors and he has also been appointed as Chairman of CURE's Audit Committee. Rob Davidson brings a deep understanding of the CURE pipeline and provides expertise in continued new product development, patent creation, and continuity in non-dilutive ongoing deal transactions as well as years of public company experience. Rob Costantino brings a unique combination of decades of financial expertise, investing experience and shareholder advocacy, operational experience, and many years of negotiating success in closing multi-billion-dollar total company and asset sales to S&P 500 companies.
Shareholder Value and Communication and Investor Events
With increasing shareholder value being a primary focus, the Company is continuing to work on additional initiatives to enhance shareholder value and is committed to increasing visibility and communications with shareholders. During the third quarter, the Company participated in three investor conferences in New York, Florida and California making presentations to investors, meeting with potential business development partners and conducting one-on-one meetings with investors. To view a replay of our CEO's October 25th presentation and Q&A click on the following link:
Link to Oct 25 2022 CEO presentation at LD Micro Main Event Investor Conference
Our CEO also recently presented and held one-on-one meetings with investors at the following investor conference with others to follow:
November 14th - Q4 Investor Summit in New York City
In summary, the recent $20 million asset sale has helped us increase our cash position and strengthen our balance sheet. Since the announcement of that non-dilutive deal and positive management and Board of Director additions, our team has been working diligently on several initiatives aligned with our guiding vision of enhancing shareholder value by utilizing our proprietary technology to differentiate ourselves from our competition and producing quality high-margin products with improved safety, efficacy, and consumer experience. Our new marketing programs are showing early encouraging results, as we continue to focus heavily on accelerating our high margin sales in the U.S. as well increasing our international presence and sales in the coming year, which is supported by our continuing work on new products and patents. We have strengthened our Board of Directors and Corporate Governance with recent Board and finance team additions including a strong Controller who joined us in November following the addition of a strong public company experienced Chief Financial Officer earlier this year. We have bolstered shareholder outreach through investor conferences across the country in the past two months and through other discussions to ensure that our turnaround strategy is universally understood and that we understand shareholders' key concerns. Our strategy is aligned with the interests of our investors and consistent with our overall guiding principle of driving long term shareholder value.
For further details, please visit our website to review our most recent Form 10-Q filed on November 21, 2022 at: http://www.curepharmaceutical.com/investors/sec-filings/
CURE Pharmaceutical Holding Corp.
CURE Pharmaceutical is a broad platform technology company that develops proprietary nutraceutical and topical delivery systems and currently holds fifteen patents. The technology offers a number of unique immediate- and controlled-release delivery vehicles designed to improve product efficacy, safety, and consumer experience for a wide range of active ingredients. The Company will continue down the path of creating new innovative technology that is part of its incubator strategy.
About The Sera Labs, Inc.
The Sera Labs, Inc. ("Sera Labs"), a wholly-owned subsidiary of CURE, is a trusted leader in the wellness and beauty sectors utilizing cutting edge technology and high-quality products that use science-backed, proprietary formulations. More than 25 products are sold under the brand names Seratopical™, Seratopical Revolution™, SeraLabs™, and Nutri-Strips™. Sera Labs sells its products at affordable prices, making them easily accessible on a global scale and is strategically positioned to grow its beauty and wellness products into household brands. Sera Labs products are sold Direct to Consumer with a subscribe and save option, as well as in major national drug, grocery and mass retailers. For more information visit: http://Seratopicalrevolution.com, http://Seratopical.com, http://Seralabshealth.com and follow Sera Labs on Instagram at @seratopical, as well as on Twitter and Facebook.
Forward Looking Statement
This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, which statements are subject to considerable risks and uncertainties. Forward-looking statements include all statements other than statements of historical fact contained in this press release, including statements regarding the future growth and success of our organization. We have attempted to identify forward-looking statements by using words such as "anticipate," "believe," "could," "estimate," "expected," "intend," "may," "plan," "predict," "project," "should," "will," or "would," and similar expressions or the negative of these expressions.
Forward-looking statements represent our management's current expectations and predictions about trends affecting our business and industry and are based on information available as of the time such statements are made. Although we do not make forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy or completeness. Forward-looking statements involve numerous known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements predicted, assumed or implied by the forward-looking statements. Some of the risks and uncertainties that may cause our actual results to materially differ from those expressed or implied by these forward-looking statements are described in the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended December 31, 2021, as well as in our Quarterly Reports on Form 10-Q and other filings with the Securities and Exchange Commission.
Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable law, we expressly disclaim any intent or obligation to update any forward-looking statements, or to update the reasons actual results could differ materially from those expressed or implied by these forward-looking statements, whether to conform such statements to actual results or changes in our expectations, or as a result of the availability of new information.
Contacts:
Investor Relations
Hanover International Inc.
(760) 564-7400
investor@curepharma.com
SOURCE: CURE Pharmaceutical Holding Corp.
View source version on accesswire.com:
https://www.accesswire.com/727677/CURE-Pharmaceutical-Reports-Third-Quarter-2022-Results-With-Strong-Sequential-and-Year-Over-Year-Revenue-Increases-and-Continued-High-Margins
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
$AGYP recent JV announcement with Walker Green Tech. On watch for big update. Only 47M float >>
Allied Energy Corp.
https://alliedengycorp.com/
Allied Energy Enters into Joint Venture Agreement with Walker Green Tech
https://www.marketwatch.com/press-release/allied-energy-enters-into-joint-venture-agreement-with-walker-green-tech-2022-10-19?mod=mw_quote_news_seemore
WalkerGreen Tech CEO, Ladda C. Walker, commented on the news: "By entering into the joint-venture agreement with Allied Energy and River Energy Group, LLC, WGT sees the new way to not only lower emissions but to monetize stranded natural gas and perfect solutions for the cryptocurrency industry."
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP Q3 2022 versus Q3 2021
The key to a meaningful comparison of end of period August ’22 to August ’21 is to recognize that August ’21 was at the height of Pandemic exuberance, recording the highest monthly sales across the entire industry. A key comparison to better understand the challenge and how the company’s brands have been gaining market share is to look at weight sold in grams and compare resulting revenue. It shows a 42% increase in product sales but a 6% decrease in comparable revenue. The company has answered price pressures with a multi-faceted strategy which allows for share capture while introducing higher margin brands and product lines.
https://www.barrons.com/articles/pervasip-announces-3rd-quarter-financials-01666098405?mod=md_stockoverview_new
$AITX Investor Open House and RAD Technology Reveal Details Released
Event to Showcase Solutions from AITX Subsidiaries RAD, RAD-M and RAD-G
Detroit, Michigan, Nov. 21, 2022 (GLOBE NEWSWIRE) -- Artificial Intelligence Technology Solutions, Inc., (the Company) (OTCPK:AITX), along with its wholly owned subsidiary, Robotic Assistance Devices Inc. (RAD), today announced details regarding the Company's December 7, 2022 Investor Open House and Technology Reveal. The event will be held at the Company's manufacturing facility, the REX, located in Ferndale, Michigan.
"If you're in the security services or #Proptech industries, a follower of anything AI related, part of the AITX community, or just into cool stuff, you need to be part of this event," said Steve Reinharz, CEO of AITX and RAD. "We will be reviewing and demonstrating the latest developments from all RAD subsidiaries, and I am so excited to announce that the main event will be the introduction of RADDOG."
RADDOG(TM) is the RAD's quadruped robot dog, developed specifically for the security services, logistics, utilities, and property management industries. Much more than just another robot dog, RADDOG integrates RAD-G's RADPack plus the entire RAD ecosystem of connectivity. This innovative AI-based infrastructure enables RADDOG to communicate with, and be autonomously dispatched by other RAD devices, creating an independent stationary and mobile security and intrusion preemption footprint.
The Company confirmed that the Open House agenda will include updates on existing RAD solutions including ROSA 3.1, AVA 3.1, and RIO, plus a live demonstration of RAD's award-winning Firearm Detection AI analytic. Also planned is the introduction of ROSS (RAD Operations System Software). ROSS connects previously deployed IP-based security cameras to the RAD network of applications and AI-based analytics.
"For the first time, we will have several security industry luminaries on stage with us," said Mark Folmer, CPP, FSyI, President of RAD. "It's important that we present the state of the security industry and how RAD solutions are becoming mainstream by the distribution channel and corporate end-users."
Those interested in attending the AITX Investor Open House and Technology Reveal can register online at tinyurl.com/2xv94nbw. For those unable to attend the event in person, it will be livestreamed at 4:30pm ET on AITX's YouTube channel www.youtube.com/aitxrad.
AITX through its subsidiary, Robotic Assistance Devices, Inc. (RAD), is redefining the $25 billion (US) security and guarding services industry through its broad lineup of innovative, AI-driven Solutions-as-a-Service business model. RAD solutions are specifically designed to provide a cost savings to businesses of between 35%-80% when compared to the industry's existing and costly manned security guarding and monitoring model. RAD delivers this tremendous costs savings via a suite of stationary and mobile robotic solutions that complement, and at times, directly replace the need for human personnel in environments better suited for machines. All RAD technologies, AI-based analytics and software platforms are developed in-house.
RAD has a sales pipeline of over 35 Fortune 500 companies and numerous other client opportunities. RAD expects to continue to attract new business as it converts its existing sales opportunities into deployed clients generating a recurring revenue stream. Each Fortune 500 client has the potential of making numerous reorders over time.
AITX has filed for up listing to the OTCQB. Future announcements will be made regarding the status of the OTCQB application.
CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this news release other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of Artificial Intelligence Technology Solutions to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, to meet business and financial goals including projections and forecasts, and other risks. No information contained in this news release should be construed as any indication whatsoever of the Company's future stock price, revenues, or results of operations. Additionally, industry data provided herein is of no predictive value regarding the future sale of the Company's products. Artificial Intelligence Technology Solutions undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in Artificial Intelligence Technology Solutions expectations.
About Artificial Intelligence Technology Solutions (AITX)
AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX's RAD, RAD-M and RAD-G companies help organizations streamline operations, increase ROI, and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staffs and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education, and healthcare. To learn more, visit http://www.aitx.ai, http://www.stevereinharz.com, http://www.radsecurity.com,radgroup.ai, and http://www.radlightmyway.com, or follow Steve Reinharz on Twitter @SteveReinharz.
###
Steve Reinharz
949-636-7060
@SteveReinharz
Attachment
Artificial Intelligence Technology Solutions, Inc.
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP Artizen™ is the 9th largest cannabis consumer brand in North America according to MJBiz Magazine, November 2021. Pervasip acquired the Artizen IP and made Artizen the first of possibly many consumer focused brands in our brand arsenal.
https://www.pervasip.net/artizen
$PVSP we are Artizen cannabis and we are expanding rapidly nationwide and international markets too!
$PVSP's Financial Outlook Q3 2022 through Q4 2023:
Reach $2.0 million in monthly revenue by end of Q1 2023
$PVSP Pervasip Corp. (PVSP) is a developer of companies and technologies in high value emerging markets with a focus on cannabis and the medical use of fungi and psychedelics
$PVSP Artizen™ Developed in the early days of 2014 on the back of years of experience in medical cannabis, the early founding members decided to grow some of the Northwest’s most well-known strains, add new genetics and create a brand of premium flower products that would eventually establish Artizen as one of the premier consumer brands in Washington State
Followers
|
839
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
48834
|
Created
|
04/12/12
|
Type
|
Free
|
Moderator logical cash | |||
Assistants bra1loga TechnoAnalyst The Bull Investment Group |
Posts Today
|
0
|
Posts (Total)
|
48834
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |